Fibroblast growth factor 21 as a biomarker for long-term complications in organic acidemias
ConclusionThis study demonstrates the potential role of FGF-21 as a biomarker for long-term complications in classical organic acidemias, attributed to mitochondrial dysfunction.
Source: Journal of Inherited Metabolic Disease - Category: Internal Medicine Source Type: research
More News: Brain | Cardiology | Cardiomyopathy | Heart | Internal Medicine | Mitochondrial Disease | Neurology | Organic | Renal Failure | Study